Renal Cancer Highlights

HAMBURG, GERMANY (UroToday.com) - The authors investigated 449 consecutive patients with hematuria but without a history for urothelial cancer of the bladder.

HAMBURG, GERMANY (UroToday.com) - With a tissue microarray, the expression of mTOR, phosphorylated mTOR (p-mTOR), and 4E binding protein in different tumor tissue samples were analyzed.

HAMBURG, GERMANY (UroToday.com) - In a clinical database on patients with advanced or metastatic renal cell carcinoma (RCC), the first 622/1000 planned patients from > 100 centers were analyzed.

HAMBURG, GERMANY (UroToday.com) - The authors looked at 35 patients with metastatic renal cell carcinoma showing primary resistance to the first tyrosine kinase inhibitor (TKI, 28 patients receiving sunitinib and 5 patients receiving sorafenib).

HAMBURG, GERMANY (UroToday.com) - The authors from two German academic centers analyzed their database with regard to elective nephron-sparing surgery for tumors > 7 cm.

HAMBURG, GERMANY (UroToday.com) - The authors investigated 4,684 patients from 6 clinical trials and 2 expanded-access trials and analyzed the median dosage of sorafenib in all patients, elderly patients and patients having received sorafenib for > 12 months.